arXiv · 2006.05365
Vocal markers from sustained phonation in Huntington's Disease
Abstract
Disease-modifying treatments are currently assessed in neurodegenerative diseases. Huntington's Disease represents a unique opportunity to design automatic sub-clinical markers, even in premanifest gene carriers. We investigated phonatory impairments as potential clinical markers and propose them for both diagnosis and gene carriers follow-up. We used two sets of features: Phonatory features and Modulation Power Spectrum Features. We found that phonation is not sufficient for the identification of sub-clinical disorders of premanifest gene carriers. According to our regression results, Phonatory features are suitable for the predictions of clinical performance in Huntington's Disease.
Explore related subjects
Keep this discovery
Rachid Riad, Hadrien Titeux, Laurie Lemoine, Justine Montillot, Jennifer Hamet Bagnou, Xuan Nga Cao, Emmanuel Dupoux, Anne-Catherine Bachoud-Lévi. 2020-06-09. Vocal markers from sustained phonation in Huntington's Disease. https://arxiv.org/abs/2006.05365
Cite the original work for its findings. Save a collection to share your selection of sources.